Auteurs
Merge
Accueil
Racine
Merge
Exploration
Accueil
Racine
Accueil
Racine

Serveur d'exploration Tocilizumab - Merge (Accueil)

Index « Auteurs » - entrée « A. Kaneko »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
A. K. Mcdiarmid < A. Kaneko < A. Kang  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 13.
Ident.Authors (with country if any)Title
002B62 (2013) Y. Yabe [Japon] ; T. Kojima ; A. Kaneko ; Y. Kanayama ; Y. Hirano ; T. Shioura ; K. Saito [Japon] ; N. Asai ; T. Kobayakawa ; N. IshiguroSAT0143 Analysis of Patients Who Obtained Remission by Disease Activity Score After Tocilizumab Treatment But Still had Low Disease Activity by Clinical Disease Activity Index, and Examination of Points for Treatment Intensification
002C00 (2013) H. Ishikawa ; Y. Hirano ; A. Kaneko ; D. Kida ; T. Sato ; T. Kojima ; T. Kanamono [Japon] ; N. IshiguroSAT0093 Pregnancy in patients with rheumatoid arthritis treated witn biological agents: Results of the 8-year of japanese tbc registry
002E22 (2013) H. Ishikawa ; H. Kanda ; D. Kida ; A. Kaneko ; M. Katayama [Japon] ; T. SatoFRI0237 Study of the antibody titer by influenza vaccination in rheumatoid arthritis patients treated with biological agents
002E42 (2013) A. Kaneko [Japon] ; D. Kida [Japon] ; H. Ishikawa [Japon]FRI0217 Extended drug interval trial to clarify the efficacy of tocilizumab after stable status in
002E50 (2013) T. Matsubara ; K. Okuda ; J. Chiba [Japon] ; A. Takayama [Japon] ; H. Inoue ; T. Sakurai ; H. Wakabayashi ; A. Kaneko ; K. Sugimoto ; H. Yamazaki ; T. Takanashi ; Y. Takasaki [Japon] ; N. Tamura [Japon] ; M. Ogasawara [Japon] ; M. Inoo ; I. Onishi ; S. Kawai [Japon] ; R. Nohara [Japon]FRI0207 A phase I/II clinical trial of intra-articular administration of ARG098, an anti-FAS IGM monoclonal antibody, in knee joint synovitis of japanese patients with rheumatoid arthritis
003081 (2013) Y. Hirano ; N. Takahashi ; A. Kaneko [Japon] ; D. Kida [Japon] ; Y. Oishi ; T. Kojima ; N. IshiguroAB0591 Analysis of rheumatoid arthritis patients who were treated with abatacept with rapid effectiveness from japanese multicenter registry system of biological therapy
003082 (2013) Y. Yabe [Japon] ; T. Kojima ; A. Kaneko ; Y. Kanayama ; T. Shioura ; N. Asai ; T. Kobayakawa ; K. Saito [Japon] ; N. IshiguroAB0590 Rates of treatment continuation and remission in 97 patients with high c-reactive protein receiving tocilizumab: 2-year study based on the tsurumai biologics communication registry
003108 (2013) N. Asai ; T. Kobayakawa ; K. Saito ; T. Shioura ; Y. Yabe [Japon] ; T. Kojima ; A. Kaneko [Japon] ; N. IshiguroAB0564 Continuation and remission rates of tocilizumab treatment based on improvement in patient global assessment: 2-year study based on the tsurumai biologics communication registry
003138 (2013) H. Ishikawa [Japon] ; A. Kaneko ; D. Kida ; T. Sato ; T. Kojima [Japon] ; N. Ishiguro [Japon]AB0534 Efficacy and safety to use halfdose abatacept therapy between 24weeks in patients with rheumatoid arthritis in japanese
003161 (2013) A. Kaneko ; N. Takahashi ; D. Kida ; Y. Hirano [Japon] ; H. Ishikawa ; T. Kojima ; N. IshiguroAB0515 Predictors of clinical remission (DAS28CRP<2.6) in patients with RA who were treated with abatacept
003162 (2013) A. Kaneko [Japon] ; D. Kida [Japon] ; H. Ishikawa [Japon] ; T. Sato [Japon]AB0514 Extended drug interval trial to clarify the efficacy of tocilizumab after stable status in patients with rheumatoid arthritis
003202 (2013) Y. Hirano ; N. Takahashi ; A. Kaneko [Japon] ; D. Kida [Japon] ; Y. Oishi ; T. Kojima ; N. IshiguroAB0339 A retrospective study on rapidness of efficacy in abatacept terapy in patients with rheumatoid arthritis from japanese multicenter registry system
003203 (2013) Y. Yabe [Japon] ; T. Kojima ; A. Kaneko ; Y. Kanayama ; Y. Hirano ; T. Shioura ; K. Saito [Japon] ; N. Asai ; T. Kobayakawa ; N. IshiguroAB0338 Evaluation of tocilizumab treatment continuation rate stratified by time of start of administration

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Merge

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/Author.i -k "A. Kaneko" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/Author.i  \
                -Sk "A. Kaneko" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Merge/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Merge
   |type=    indexItem
   |index=    Author.i
   |clé=    A. Kaneko
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021